Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation
|2||Active, not recruiting||
Cystic Fibrosis Related Bone Disease: the Role of CFTR
Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
† Study has passed its completion date and status has not been verified in more than two years.